8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
RESMED INC (RMD)

ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of…

Filed with the SEC on · Summarized by InvestorsBot

ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of operations (Exhibit 99.1). Signed by CFO Brett Sandercock. Investors should read the release for quarter results/guidance. 📄 $RMD #8K #earnings

The 8‑K also includes the Inline XBRL cover page (Exhibit 104) — machine‑readable financial data is available for analysis. Use XBRL to pull reported metrics. 📊 $RMD #XBRL #fintech

Filing date Jan 29, 2026 — immediate market relevance: review the press release and XBRL for any material changes to ops, revenue or outlook. 🔎 $RMD #healthcare #investing

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from RESMED INC

ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share.

8-K · January 29, 2026

ResMed ($RMD) furnished a press release (Exhibit 99.1) on Jan 29, 2026 reporting results for the quarter…

8-K · January 29, 2026